Table 7.
Functional annotation results of target genes regulated by has-miR-193b-3p
| Category | Term | Genes | p value |
|---|---|---|---|
| KEGG_PATHWAY | hsa05221:Acute myeloid leukemia | CCND1, KIT, KRAS, SOS2, RUNX1T1 | 3.84E−04 |
| KEGG_PATHWAY | hsa05200:Pathways in cancer | MAPK10, ARHGEF12, CCND1, KIT, KRAS, LAMC2, LAMC1, ETS1, SOS2, RUNX1T1 | 5.87E−04 |
| KEGG_PATHWAY | hsa04151:PI3K-Akt signaling pathway | CCND1, KIT, TSC1, KRAS, LAMC2, LAMC1, OSMR, YWHAZ, SOS2 | 1.14E−03 |
| KEGG_PATHWAY | hsa04917:Prolactin signaling pathway | MAPK10, CCND1, KRAS, SOS2 | 9.68E−03 |
| KEGG_PATHWAY | hsa04014:Ras signaling pathway | MAPK10, KIT, RRAS2, KRAS, ETS1, SOS2 | 1.28E−02 |
| KEGG_PATHWAY | hsa04012:ErbB signaling pathway | MAPK10, ERBB4, KRAS, SOS2 | 1.68E−02 |
| KEGG_PATHWAY | hsa05231:Choline metabolism in cancer | MAPK10, TSC1, KRAS, SOS2 | 2.48E−02 |
| KEGG_PATHWAY | hsa04510:Focal adhesion | MAPK10, CCND1, LAMC2, LAMC1, SOS2 | 3.88E−02 |
| KEGG_PATHWAY | hsa04068:FoxO signaling pathway | MAPK10, CCND1, KRAS, SOS2 | 5.07E−02 |
| KEGG_PATHWAY | hsa04910:Insulin signaling pathway | MAPK10, TSC1, KRAS, SOS2 | 5.45E−02 |
| KEGG_PATHWAY | hsa04664:Fc epsilon RI signaling pathway | MAPK10, KRAS, SOS2 | 6.71E−02 |
| KEGG_PATHWAY | hsa04010:MAPK signaling pathway | MAPK10, TAOK1, RRAS2, KRAS, SOS2 | 7.20E-02 |